EMEA-002572-PIP02-19-M01

Table of contents

Key facts

Active substance
Soticlestat
Therapeutic area
Neurology
Decision number
P/0491/2021
PIP number
EMEA-002572-PIP02-19-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral formulation
Condition(s) / indication(s)
  • Treatment of Dravet syndrome
  • Treatment of Lennox-Gastaut syndrome
Route(s) of administration
  • Oral use
  • Gastric use
  • Intestinal use
Contact for public enquiries
Takeda Pharma A/S

Tel. +44 (0)3333000181
E-mail: medinfoEMEA@takeda.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating